Passage Bio Net Interest Income Over Time
| PASG Stock | USD 12.87 1.41 9.87% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Passage Bio Performance and Passage Bio Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Interest Income Analysis
Compare Passage Bio and related stocks such as NuCana PLC, MetaVia, and Lisata Therapeutics Net Interest Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NCNA | 283 K | 283 K | 283 K | 283 K | 283 K | 283 K | 283 K | 208 K | 1.1 M | 1 M | 246 K | 103 K | 669 K | 754 K | 358 K | 411.7 K | 578.7 K |
| MTVA | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 39 K | 14 K | (2.2 M) | 461 K | 920 K | 1.1 M | 1.1 M |
| LSTA | (5 K) | (5 K) | (5 K) | (5 K) | (5 K) | (5 K) | (5 K) | (5 K) | (5 K) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ALLR | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (3.3 M) | (227 K) | (1.8 M) | (193 K) | (354 K) | (120 K) | (138 K) | (144.9 K) |
| GDTC | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (105.5 K) | (114.3 K) | (123.1 K) | 234.4 K | 297.4 K | 342 K | 359.1 K |
| ENLV | 60 K | 60 K | 60 K | 60 K | 60 K | 60 K | 60 K | 34 K | 135 K | 231 K | 219 K | (208 K) | 821 K | 1.6 M | 1.1 M | 1.2 M | 1.3 M |
| CING | 101 K | 101 K | 101 K | 101 K | 101 K | 101 K | 101 K | 101 K | 101 K | 101 K | (100.3 K) | (30.6 K) | (174.5 K) | (768.2 K) | 99.2 K | 89.3 K | 93.8 K |
| CLGN | (49.4 K) | (49.4 K) | (49.4 K) | (49.4 K) | (49.4 K) | (49.4 K) | (49.4 K) | (100.1 K) | (59.7 K) | (73 K) | 6 K | 182 K | 172 K | 504 K | 721 K | 829.1 K | 870.6 K |
| XCUR | (724 K) | (724 K) | (724 K) | (724 K) | (724 K) | (724 K) | (724 K) | (795 K) | (672 K) | (608 K) | 399 K | (1.6 M) | (580 K) | 32 K | (10 K) | (11.5 K) | (12.1 K) |
| CASI | (26.1 K) | (26.1 K) | (26.1 K) | (26.1 K) | (26.1 K) | (26.1 K) | (26.1 K) | 1 K | 40 K | 1.1 M | 866 K | 321 K | 127 K | 614 K | (332 K) | (381.8 K) | (362.7 K) |
Passage Bio and related stocks such as NuCana PLC, MetaVia, and Lisata Therapeutics Net Interest Income description
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.My Equities
My Current Equities and Potential Positions
| Passage Bio | PASG |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | One Commerce Square, |
| Exchange | NASDAQ Exchange |
USD 12.87
Check out Passage Bio Performance and Passage Bio Correlation. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Passage Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.